RI Bio
RI Bio is the trade group and singular voice of southeastern New England’s life sciences industry. It advances the industry through education, collaboration, and advocacy, connecting entrepreneurs with universities, government agencies, medical centers, professional associations, trade organizations, service providers, and investors to foster innovation, create jobs, and generate economic impact. RI Bio aims to grow the life sciences economy in Rhode Island and Southeastern New England, promoting an equitable, innovative, and thriving bioscience sector that improves health, protects the climate, and nourishes humanity.
Industries
Nr. of Employees
small (1-50)
Products
RI Bio Network Program
A multi-year program launched with federal funding designed to commercialize and expand life-science startup activity through business and technical assistance and ecosystem coordination.
Regional life-sciences ecosystem evaluation report
Analytical report evaluating the regional life-sciences ecosystem and recommending actions to build innovation capacity and infrastructure.
RI Bio Network Program
A multi-year program launched with federal funding designed to commercialize and expand life-science startup activity through business and technical assistance and ecosystem coordination.
Regional life-sciences ecosystem evaluation report
Analytical report evaluating the regional life-sciences ecosystem and recommending actions to build innovation capacity and infrastructure.
Services
Subscription-based membership offering access to a member directory, consolidated vendor discounts, informational resources, and member-only program access.
Instructor-led and self-guided courses covering laboratory skills, biotech boot camps, leadership, and advanced project management for life-sciences workers.
Short workshops, incubator cohorts and accelerator partnerships providing one-on-one coaching, cohort learning, and investor exposure for early-stage ventures.
Legislative engagement, testimony preparation, briefings and coordination of state and federal advocacy activities on behalf of the regional life-sciences sector.
Organization of large-scale expos, specialist panels, workshops and webinars focused on scientific, technical and business topics.
Programs and partnerships funded to support translational research commercialization, provide technical/business assistance to startups, and facilitate investor introductions.
Subscription-based membership offering access to a member directory, consolidated vendor discounts, informational resources, and member-only program access.
Instructor-led and self-guided courses covering laboratory skills, biotech boot camps, leadership, and advanced project management for life-sciences workers.
Short workshops, incubator cohorts and accelerator partnerships providing one-on-one coaching, cohort learning, and investor exposure for early-stage ventures.
Legislative engagement, testimony preparation, briefings and coordination of state and federal advocacy activities on behalf of the regional life-sciences sector.
Organization of large-scale expos, specialist panels, workshops and webinars focused on scientific, technical and business topics.
Programs and partnerships funded to support translational research commercialization, provide technical/business assistance to startups, and facilitate investor introductions.
Expertise Areas
- Workforce development and professional training
- Startup incubation and acceleration
- Commercialization support and translational assistance
- Biomanufacturing and wet-lab infrastructure development
Key Technologies
- Digital health technologies
- Telehealth
- Digital acceleration hubs
- Biomanufacturing
News & Updates
A successful event with over 300 attendees, featuring keynote speakers, panels, exhibits, and networking, showcasing Rhode Island's life sciences industry.
Various programs including leadership training, ecosystem reports, and collaborations to expand the life sciences sector in Rhode Island.
Federal grants awarded to support health care startups and translational research collaborations in RI.
Amgen released its 8th edition of the Biosimilar Trends Report, highlighting cost savings and market competition in biosimilars.
Andrew Galvin, SVP of CBRE, joined RI Bio's board, bringing expertise in real estate and regional development.
Dennis Keefe, CEO of Care New England, discusses healthcare transformation, population health, and hospital challenges.
A successful event with over 300 attendees, featuring keynote speakers, panels, exhibits, and networking, showcasing Rhode Island's life sciences industry.
Various programs including leadership training, ecosystem reports, and collaborations to expand the life sciences sector in Rhode Island.
Federal grants awarded to support health care startups and translational research collaborations in RI.
Amgen released its 8th edition of the Biosimilar Trends Report, highlighting cost savings and market competition in biosimilars.
Andrew Galvin, SVP of CBRE, joined RI Bio's board, bringing expertise in real estate and regional development.
Dennis Keefe, CEO of Care New England, discusses healthcare transformation, population health, and hospital challenges.